All right folks, with all the dd that has been provided coupled with the dd you've done yourself, let's talk fundamental valuations AFTER the IND approval and successful trials.

Before we proceed, of the 18 BILLION dollar market that is pharma, with the success of HemaXellerate (and we will just discuss HemaXellerate right now), what percentage of that market do you think BMSN will have?

Educated guesses everyone... (scram one-eyed)